401 related articles for article (PubMed ID: 25495133)
1. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
3. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.
Ojer P; Iglesias T; Azqueta A; Irache JM; López de Cerain A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):206-17. PubMed ID: 26493712
[TBL] [Abstract][Full Text] [Related]
4. Is nanotechnology a boon for oral drug delivery?
Agrawal U; Sharma R; Gupta M; Vyas SP
Drug Discov Today; 2014 Oct; 19(10):1530-46. PubMed ID: 24786464
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
Florek J; Caillard R; Kleitz F
Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
Yellepeddi VK; Ghandehari H
Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
[No Abstract] [Full Text] [Related]
7. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
9. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
Kumari A; Kumar V; Yadav SK
Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
[TBL] [Abstract][Full Text] [Related]
12. Oral bioavailability: issues and solutions via nanoformulations.
Pathak K; Raghuvanshi S
Clin Pharmacokinet; 2015 Apr; 54(4):325-57. PubMed ID: 25666353
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
14. Modern drug delivery strategies applied to natural active compounds.
Puglia C; Lauro MR; Tirendi GG; Fassari GE; Carbone C; Bonina F; Puglisi G
Expert Opin Drug Deliv; 2017 Jun; 14(6):755-768. PubMed ID: 27606793
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
[TBL] [Abstract][Full Text] [Related]
18. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
19. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
[TBL] [Abstract][Full Text] [Related]
20. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
